Diagnosis and treatment of psychiatric comorbidity in alcoholics and drug addicts

Psychiatric Annals

Volumn 28, Issue 12, 1998, Pages 705-708

  Beedle, Dennis D ^a,b,e   Mcgovern, Mark P ^c,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032279202     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19981201-09     Document Type: Article

References (16)

1. Miller WR, McCrady BS. The importance of research on Alcoholics Anonymous. In: McCrady BS, Miller WR, eds. Research on Alcoholics Anonymous: Opportunities and Alternatives. New Brunswick, NJ: Rutgers Center of Alcohol Studies; 1993:3-11.
2. Morgenstern J, Labouvie E, McCardy BS, Kahler CW, Frey RM. Affiliation with Alcoholics Anonymous after treatment: a study of its therapeutic effects and mechanisms of action. J Consult Clin Psychol. 1997;65:768-777.
3. Minkoff K. Treating the dually diagnosed in psychiatric settings. In: Miller NS, ed. Treating Coexisting Psychiatric and Addictive Disorders. Center City, MN: Hazelden; 1994:53-68.
4. Hoffman GW Jr, DiRito DC, McGill EC. Three-month follow-up of 28 dual diagnosis inpatients. Am J Alcohol Abuse. 1993;19:79-88.
5. Montrose K, Daley DC. Celebrating Small Victories: A Primer of Approaches and Attitudes for Helping Patients With Dual Disorders. Center City, MN: Hazelden; 1995:3-51.
6. Galanter M, Castaneda R, Ferman J. Substance abuse among general psychiatric patients: place of presentation, diagnosis, and treatment. Am J Drug Alcohol Abuse. 1988;14:211-235.
7. Drake RE, Noordsy DL. Case management for people with coexisting severe mental disorder and substance use disorder. Psychiatric Annals. 1994;24:427-431.
8. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264:2511-2518.
9. Imhof JE. Countertransference issues in the treatment of drug and alcohol addiction. In: Miller NS, ed. Comprehensive Handbook of Drug and Alcohol Addiction. New York: Marcel Dekker; 1991:931-946.
10. Meyer RE. How to understand the relationship between psychopathology and addictive disorders. In: Myer RE, ed. Psychopathology and Addictive Disorders. New York: Guilford; 1986:3-16.
11. Miller WR, Rollnick S, eds. Motivational Interviewing. New York: Guilford; 1991:51-124.
12. Miller NS, Hoffman NG, Ninonuevo F, Astrachan BM. Lifetime diagnosis of major depression as a multivariate predictor of treatment outcome for inpatients with substance use disorders from abstinence-based programs. Ann Clin Psychiatry. 1997;9:127-137.
13. Grant BF. The influence of comorbid major depression and substance use disorders on alcohol and drug treatment: results of a national survey. In: Onken LS, Blaine JD, Genser S, Horton AM Jr, eds. NIDA Research Monograph No. 172. Rockville, MD: National Institute of Drug Abuse; 1997:4-15.
14. McLellan AJ, Luorsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug treatments: role of psychiatric severity. Arch Gen Psychiatry. 1983;40:620-625.
15. Minkoff K. Program components of a comprehensive integrated care system for seriously mental ill patients with substance disorders. In: Minkoff K, Drake RE, eds. Dual-Diagnosis of Major Mental Illness and Substance Disorder. San Francisco: Jossey-Bass; 1991:13-27.
16. Miller NS. Psychiatric comorbidity occurrence and treatment. Alcohol Health Res World. 1994;18:261-264.